Lisdexamfetamine - Shionogi/Takeda
At a glance
- Drug Originator New River Pharmaceuticals
- Drug Licenced by Shionogi
- Drug Class Amides; Amphetamines; Antipsychotics; Behavioural disorder therapies; Drug withdrawal therapies; Neuropsychotherapeutics; Sleep disorder therapies; Small molecules
- Mechanism of Action Adrenergic uptake inhibitors; Dopamine uptake inhibitors
- USA Patent Applicants TAKEDA PHARMS USA
- USA Patents 18
- NDAs 2
- Patent Applications 293
Table of Contents
Disclaimer